Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Cardiology/Vascular Diseases | Endocrinology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Neurex
Approval Status: Approved September 1997
Treatment Area: hypertension
Neurex Corporation received marketing clearance from the U.S.
Food and Drug Administration (FDA) for Corlopam. Corlopam is an
intervenous treatment for severe high blood pressure. Corlopam is
administered in the hospital over a six-hour to 48-hour period to
relieve severe hypertensive spikes.
